Immunotechnology logo Elsevier logo

Publisher: Elsevier

Volume 2, Number 2, June 1996
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Gene vaccines
pp. 77-83(7)
Author: Wahren B.

Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes
pp. 85-95(11)
Authors: Brumeanu T.-D.; Bot A.; Bona C.A.; Dehazya P.; Wolf I.; Zaghouani H.

Separation of E. coli expressing functional cell-wall bound antibody fragments by FACS
pp. 97-102(6)
Authors: Fuchs P.; Weichel W.; Dubel S.; Breitling F.; Little M.

Immunoreactivity of allergen (Bet v 1) conjugated to crystalline bacterial cell surface layers (S-layers)
pp. 103-113(11)
Authors: Jahn-Schmid B.; Graninger M.; Glozik M.; Kupcu S.; Ebner C.; Unger F.M.; Sleytr U.B.; Messner P.

Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis
pp. 115-126(12)
Authors: Kola A.; Baensch M.; Bautsch W.; Hennecke M.; Klos A.; Casaretto M.; Kohl J.

Affinity maturation of recombinant antibodies using E.coli mutator cells
pp. 127-143(17)
Authors: Irving R.A.; Kortt A.A.; Hudson P.J.

pDAP2: a vector for construction of alkaline phosphatase fusion-proteins
pp. 145-150(6)
Authors: Kerschbaumer R.J.; Hirschl S.; Schwager C.; Ibl M.; Himmler G.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A